Epidermolysis Bullosa Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Epidermolysis bullosa is a genetic disorder characterized clinically by blister formation from mechanical trauma. There are four main types with additional sub-types identified. There is a spectrum of severity, and within each type, one may be either midely or severely affected. Epidermolysis bullosa range from being a minor inconvenience requiring modification of some activities, to being completely disabling and, in some cases, fatal.

Friction causes blister formation, blisters can form anywhere on the surface of the skin, within the oral cavity and in more severe forms many also involve the external surface of the eyes, as well as the respiratory, gastrointestinal and genitourinary tracts. In some form of the dieases,disfiguring scars and disabling musculoskeletal deformities occur.

Market Dynamics

The increasing prevalence of epidermolysis bullosa globally, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the global epidermolysis bullosa market over the forecast period.

For instance, in March 2020, Abeona Therapeutics Inc., a gene and cell development company announced that the first patient treated in a pivotal phase III clinical trial evaluating EB - 101 gene therapy for recessive dystrophic epidermolysis bullosa.

Key features of the study:

This report provides an in-depth analysis of the global epidermolysis bullosa market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global epidermolysis bullosa market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Amryt Pharma, Abeona Therapeutics, Castle Creek Pharmaceuticals, RegeneRx, Krystal Biotech, RHEACELL GmbH, Holostem Terapie Avanzate, StemRim/Shionogi, and Phoenix Tissue Repair
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global epidermolysis bullosa market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epidermolysis bullosa market

Detailed Segmentation:

Global Epidermolysis Bullosa Market, By Product Type:
- Antibiotic
- Analgesics
- Others
Global Epidermolysis Bullosa Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Epidermolysis Bullosa Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Amryt Pharma.*
  - Company Overview
  - Material Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Abeona Therapeutics
- Castle Creek Pharmaceuticals
- RegeneRx
- Krystal Biotech
- RHEACELL GmbH
- Holostem Terapie Avanzate
- StemRim/Shionogi
- Phoenix Tissue Repair

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2214

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Mergers & Acquisitions

4. Global Epidermolysis Bullosa Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
Impact on Clinical Trials
Government Initiatives

5. Global Epidermolysis Bullosa Market, By Product Type, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Antibiotic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Analgesic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Epidermolysis Bullosa Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Epidermolysis Bullosa Market, By Region, 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
North America
- Market Size and Forecast, By Product Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Product Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Product Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Product Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Product Type, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Amryt Pharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Abeona Therapeutics
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Castle Creek Pharmaceuticals
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- RegeneRx
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Krystal Biotech
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- RHEACELL GmbH
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Holostem Terapie Avanzate
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- StemRim/Shionogi
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
- Phoenix Tissue Repair
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

Epidermolysis Bullosa Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030